Your browser doesn't support javascript.
loading
Supramolecular Chemotherapy: Complexation by Carboxylated Pillar[6]arene for Decreasing Cytotoxicity of Nitrogen Mustard to Normal Cells and Enhancing Its Antitumor Efficiency against Breast Cancer.
Zhang, Jin Long; Zhang, Xiao Wei; Yuan, Bing; Zhang, Heng; Wang, Xing Zhi; Wang, Hao; Zhao, Hong Wei.
Afiliação
  • Zhang JL; Capital Medical University Affiliated Beijing Tongren Hospital Department of Radiology, Beijing 100730, China.
  • Zhang XW; Hubei University, Wuhan 430062, China.
  • Yuan B; Department of Interventional Radiology, Chinese PLA General Hospital, Beijing 100853, China.
  • Zhang H; Department of Radiology, Chinese PLA General Hospital Second Medical Center, Beijing 100853, China.
  • Wang XZ; Shenyang Pharmaceutical University, Shenyang 117004, China.
  • Wang H; Shenyang Pharmaceutical University, Shenyang 117004, China.
  • Zhao HW; Capital Medical University Affiliated Beijing Tongren Hospital Department of Radiology, Beijing 100730, China.
ACS Omega ; 9(10): 11829-11835, 2024 Mar 12.
Article em En | MEDLINE | ID: mdl-38497008
ABSTRACT
Advances in chemotherapeutic strategies are urgently required to improve antitumor efficiency. Herein, a carboxylated pillar[6]arene (CP6A) was employed to load chemotherapy medication, nitrogen mustard (NM), via forming a direct host-guest complex, as this helps to decrease the cytotoxicity of NM on normal mammary epithelial cells. Attributed to the stronger complexation ability of CP6A for endogenous spermine (SPM) than for NM, the complexed NM could be competitively released from the CP6A cavity via replacement with SPM. This chemotherapy strategy performed well in vitro and in vivo for SPM-overexpressed cancers. In comparison with free NM, antitumor efficiency of NM/CP6A was significantly enhanced, which originated from the synergistic effect of competitive release of NM and simultaneous trapping of SPM. This strategy might guide expansion to other first-line antitumor agents to improve therapeutic efficacy and decrease side effects, thereby replenishing the possibilities of supramolecular chemotherapy.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article